Literature DB >> 15388499

Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury.

Monte S Willis1, Deborah L Carlson, J Michael Dimaio, Michael D White, D Jean White, Glenn A Adams, Jureta W Horton, Brett P Giroir.   

Abstract

We have recently demonstrated that macrophage migration inhibitory factor (MIF) is a myocardial depressant protein and that MIF mediates late, prolonged cardiac dysfunction after endotoxin challenge in mice. Because many factors, including endotoxin, have been implicated in the pathogenesis of cardiac dysfunction after burn injury, we tested the hypothesis that MIF might also be the mediator of prolonged cardiac dysfunction in this model. At 4 h after 40% total body surface area burn in anesthetized mice, serum MIF levels increased significantly compared with baseline (2.2-fold). This increase was accompanied by a significant decrease in cardiac tissue MIF levels (2.1-fold decrease compared with controls). This pattern was consistent with MIF release from preformed cytoplasmic stores in the heart and other organs. To determine whether MIF mediates cardiac dysfunction after burn injury, mice were pretreated with anti-MIF neutralizing monoclonal antibodies or isotype control antibodies. Beginning 4 h after burn injury (and continuing through 48 h), burned mice demonstrated a significantly depressed left ventricular shortening fraction of 38.6 +/- 1.8%, compared with the normal controls (56.0 +/- 2.6%). Mice treated with anti-MIF displayed an initial depression of cardiac function similar to nontreated animals but then showed rapid restoration of cardiac function with complete recovery by 24 h, which persisted for the duration of the protocol. This study is the first to demonstrate that MIF mediates late, prolonged cardiac dysfunction after burn injury and suggests that MIF blockade should be considered a therapeutic target for the treatment of burn injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388499     DOI: 10.1152/ajpheart.00189.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

1.  Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking.

Authors:  Julia L Gregory; Pam Hall; Michelle Leech; Eric F Morand; Michael J Hickey
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

2.  Amino acids from Mytilus galloprovincialis (L.) and Rapana venosa molluscs accelerate skin wounds healing via enhancement of dermal and epidermal neoformation.

Authors:  Diana L Badiu; Rafael Luque; Elena Dumitrescu; Anca Craciun; Danut Dinca
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

3.  The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Authors:  Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala
Journal:  Burns       Date:  2016-05-18       Impact factor: 2.744

4.  Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy.

Authors:  Xihui Xu; Benjamin D Pacheco; Lin Leng; Richard Bucala; Jun Ren
Journal:  Cardiovasc Res       Date:  2013-05-13       Impact factor: 10.787

5.  Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.

Authors:  Xihui Xu; Yinan Hua; Sreejayan Nair; Richard Bucala; Jun Ren
Journal:  Hypertension       Date:  2013-12-23       Impact factor: 10.190

6.  Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion.

Authors:  Dake Qi; Xiaoyue Hu; Xiaohong Wu; Melanie Merk; Lin Leng; Richard Bucala; Lawrence H Young
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

7.  Pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; David L Chinkes; Celeste C Finnerty; Gabriela Kulp; Oscar E Suman; William B Norbury; Ludwik K Branski; Gerd G Gauglitz; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

8.  A newly identified mechanism involved in regulation of human mesenchymal stem cells by fibrous substrate stiffness.

Authors:  Huihua Yuan; Yaxian Zhou; Ming-Song Lee; Yanzhong Zhang; Wan-Ju Li
Journal:  Acta Biomater       Date:  2016-06-28       Impact factor: 8.947

9.  Coculture with hematopoietic stem cells protects cardiomyocytes against apoptosis via paracrine activation of AKT.

Authors:  Mark Rosenberg; Matthias Lutz; Constantin Kühl; Rainer Will; Volker Eckstein; Jutta Krebs; Hugo A Katus; Norbert Frey
Journal:  J Transl Med       Date:  2012-06-06       Impact factor: 5.531

10.  Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor.

Authors:  Xi-Yong Yu; Hong-Mei Chen; Jia-Liang Liang; Qiu-Xiong Lin; Hong-Hong Tan; Yong-Heng Fu; Xiao-Ying Liu; Zhi-Xin Shan; Xiao-Hong Li; Hua-Zhang Yang; Min Yang; Yangxin Li; Shu-Guang Lin
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.